2020 annual financial data
ProQR Therapeutics 2020 Operating margin
ProQR Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -4,117.4%.
Operating income was -42,368,000 EUR and net income was -46,565,000 EUR.
Operating cash flow was -47,060,000 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,028,999 EUR
- Operating income
- -42,368,000 EUR
- Net income
- -46,565,000 EUR
- Operating cash flow
- -47,060,000 EUR